Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means

As reported by Decrypt

A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on Decrypt ↗

Market Samachar is a news aggregator. This article was originally published by Decrypt. Tap the button above to read the full story on their site.

INDIAN Bitcoin tops $80,000 as optimistic mood returns to crypto market Share Market Today
INDIAN Nifty Midcap index hits new high as earnings, domestic demand drive gains Share Market Today
INDIAN The House of Abhinandan Lodha enters into MoU with NITCO Share Market Today
INDIAN United Breweries expands Heineken Silver Across Kerala, Odisha and Madhya Pradesh Share Market Today
INDIAN First monthly expiry under CAS sees a minor fall in derivatives turnover Share Market Today
INDIAN HEG demerger becomes effective from 07 Sep 2026 Share Market Today
INDIAN Noumed Pharmaceuticals renews its supply agreement with leading Australian pharmacy chain Share Market Today
INDIAN Crude oil prices slide 4% as markets look past Iran sanctions Markets-Economic Times

Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means

More from Market Samachar